Form 4 for CELU Celularity Inc
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0000899243-23-005063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-10 | CELU | Diamandis Peter | Dir | M - OptEx | $0.28 | +1.07M | 1.11M | +2,963% | +$299.9K |
| D | 2023-02-14 | 2023-02-10 | CELU | Diamandis Peter | Dir | M - OptEx | $0.00 | -1.07M | 2.66M | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-10 | M | A | 1,071,000 | $0.28 | 1,107,145 | D | — | — | (F1) Includes 36,145 shares underlying restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-10 | M | D | 1,071,000 | $0.00 | 2,660,136 | D | $0.28 · — to 2027-06-02 | 1,071,000 Class A Common Stock | (F2) This option is fully vested and exercisable. |